2-151576242-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_001164507.2(NEB):c.16817A>G(p.Tyr5606Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000887 in 1,611,572 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001164507.2 missense
Scores
Clinical Significance
Conservation
Publications
- nemaline myopathy 2Inheritance: AR, AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P, Ambry Genetics
- childhood-onset nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intermediate nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- typical nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- lethal multiple pterygium syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- severe congenital nemaline myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NEB | ENST00000397345.8 | c.16817A>G | p.Tyr5606Cys | missense_variant | Exon 106 of 182 | 5 | NM_001164508.2 | ENSP00000380505.3 | ||
| NEB | ENST00000427231.7 | c.16817A>G | p.Tyr5606Cys | missense_variant | Exon 106 of 182 | 5 | NM_001164507.2 | ENSP00000416578.2 | ||
| NEB | ENST00000409198.5 | c.11714A>G | p.Tyr3905Cys | missense_variant | Exon 79 of 150 | 5 | ENSP00000386259.1 | |||
| NEB | ENST00000413693.5 | c.1007A>G | p.Tyr336Cys | missense_variant | Exon 6 of 74 | 5 | ENSP00000410961.1 |
Frequencies
GnomAD3 genomes AF: 0.0000923 AC: 14AN: 151706Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.000104 AC: 26AN: 249024 AF XY: 0.000118 show subpopulations
GnomAD4 exome AF: 0.0000884 AC: 129AN: 1459750Hom.: 0 Cov.: 30 AF XY: 0.000102 AC XY: 74AN XY: 726250 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000922 AC: 14AN: 151822Hom.: 0 Cov.: 30 AF XY: 0.0000808 AC XY: 6AN XY: 74230 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:4
Identified in individual with endometriosis; however, further research is needed to explore a possible link between variants in the NEB gene and this phenotype (PMID: 37626618); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 37626618, 38515714, 35885997) -
- -
- -
- -
Nemaline myopathy 2 Uncertain:2Benign:1
- -
- -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Inborn genetic diseases Uncertain:1
The c.11714A>G (p.Y3905C) alteration is located in exon 79 (coding exon 77) of the NEB gene. This alteration results from a A to G substitution at nucleotide position 11714, causing the tyrosine (Y) at amino acid position 3905 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at